奥曲肽辅助治疗急性胰腺炎的临床效果研究  

Effect of octreotide for adjuvant therapy of acute pancreatitis

作　　者：苏静[1] Sujing(emeishan people＇s hospital, mount emei, sichuan 614200)

机构地区：[1]峨眉山市人民医院,四川峨眉山614200

出　　处：《当代医药论丛》2018年第7期5-7,共3页

摘　　要：目的 :探讨应用奥曲肽辅助治疗急性胰腺炎的临床效果。方法 :将2016年1月至2017年6月峨眉山市人民医院收治的62例急性胰腺炎患者随机分为观察组(31例)与对照组(31例)。对对照组患者进行常规治疗,在此基础上为观察组患者加用奥曲肽进行治疗。在治疗1个疗程后对比分析两组患者的临床疗效。结果 :观察组患者治疗的总有效率为93.5%,对照组患者治疗的总有效率为75.4%,二者相比差异有统计学意义(P<0.05)。与对照组患者相比,治疗后观察组患者血清淀粉酶的水平及血清CRP的水平均较低,差异有统计学意义(P<0.05)。与对照组患者相比,观察组患者在接受治疗后其尿淀粉酶指标、血淀粉酶指标恢复正常的时间、腹部压痛、腹痛消失的时间及住院的时间均较短,差异有统计学意义(P<0.05)。结论 :应用奥曲肽辅助治疗急性胰腺炎可取得理想的效果,能较快改善患者的临床症状。objective： to explore the clinical effect of octreotide in the treatment of acute pancreatitis. Methods： the 62 patients with acute pancreatitis treated in emeishan people＇s hospital from January 2016 to June 2017 were randomly divided into observation group（31 cases） and control group（31 cases）. Routine treatment was performed in the control group, and the octreotide was treated in the observation group. The clinical efficacy of the two groups was analyzed after 1 course of treatment. Results： the total effective rate of treatment in the observation group was 93.5%, and the total effective rate of treatment in the control group was 75.4%. The difference was statistically significant（P〈0.05）. Compared with the control group, serum amylase level and serum CRP level were lower in the observed group after treatment, and the difference was statistically significant（P〈0.05）. Compared with the control group patients, observation group of patients after treatment, the urine amylase, blood amylase returned to normal abdominal pain, abdominal tenderness and disappear with the time and hospitalization time is shorter, the difference was statistically significant（P〈0.05）. Conclusion： using octreotide adjuvant therapy for acute pancreatitis can achieve the ideal effect, and can improve the clinical symptoms quickly.

关 键 词：急性胰腺炎 奥曲肽 血清CRP 

分 类 号：R657.51[医药卫生—外科学]